Neonatal Abstinence Syndrome

Neonatal Withdrawal Risk Higher With Opioids Plus Psychotropic Drugs

Neonatal Withdrawal Risk Higher With Opioids Plus Psychotropic Drugs

By

The infants of women taking opioids concomitantly with psychotropic medications were found to have a substantially heightened risk of neonatal drug withdrawal.

Neonatal Abstinence Syndrome Effectively Treated With Buprenorphine

Neonatal Abstinence Syndrome Effectively Treated With Buprenorphine

In infants with neonatal abstinence syndrome, sublingual buprenorphine reduced the duration of treatment and decreased the length of hospital stay.

Buprenorphine Beneficial in Neonatal Abstinence Syndrome

Buprenorphine Beneficial in Neonatal Abstinence Syndrome

Sublingual buprenorphine is associated with shorter duration of treatment than oral morphine for infants with neonatal abstinence syndrome.

Preventing and Managing Neonatal Abstinence Syndrome

Preventing and Managing Neonatal Abstinence Syndrome

The article reviews the epidemiology, clinical features, outcomes, prevention strategies, risk identification and management NAS.

Poor School Performance in Children With Neonatal Abstinence Syndrome

Poor School Performance in Children With Neonatal Abstinence Syndrome

Children with neonatal abstinence syndrome may be more likely to perform poorly in school.

Sign Up for Free e-Newsletters